Information on current trials
AMETHYST Trial
The Amethyst Trial is currently finalising the protocol and document set ahead of sponsor Risk Assessment (approx. scheduled for May); after that they intend to procced to full combined review by June/ July and will then be on track to begin opening sites to recruitment from the end of August.
We would welcome your sites to be involved, and look forward to receiving your Expression of Interest form back as soon as you can manage please. Download the Trial Summary here
Active trials
Closed trials
CERM (inflammation in the uterine lining and recurrent miscarriage)
Trials with published results:
GEM3 : (medical treatment of tubal ectopic pregnancy)
ALIFE2 (blood thinners for women with clotting disorders and recurrent miscarriages)
PRISM (progesterone for bleeding in early pregnancy)
TABLET (thyroxine to try and prevent miscarriage in women with thyroid antibodies)
PROMISE (progesterone to try and prevent recurrent miscarriage)